Christopher Viehbacher - Feb 7, 2024 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
President and CEO, Director
Signature
/s/ Wendell Taylor, attorney-in-fact for Christopher A. Viehbacher
Stock symbol
BIIB
Transactions as of
Feb 7, 2024
Transactions value $
$0
Form type
4
Date filed
2/9/2024, 07:56 PM
Previous filing
Dec 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Award $0 +27K $0.00 27K Feb 7, 2024 Common Stock 27K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.